Active substance
HEPATITIS-B-IMMUNOGLOBULINE
Therapeutical formulation
INJECTIEVLOEISTOF

€ 323.40 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Own risk

€ 323.40

This is the amount charged to your deductible .

Strength
500IE/ML
Supplier
Twinpharma B.V.
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/09/600/001